HistoSonics, Inc.: Series A $11M

Posted in I - Series A, Q - 1Q10, R - MID WEST, X - BPH, X - Device (Ablation), X - Histotripsy, XX - MI

HistoSonics (Ann Arbor, MI) a development stage device company focused on non-invasive image-guided tissue ablation for benign prostatic hyperplasia, closed an $11M Series A financing. Participants include Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners and TGap Ventures.

Nov

2008

Veran Medical Technologies, Inc: Series A $4.8M

Posted in I - Series A, Q - 2Q08, R - MID WEST, X - Device (Ablation), X - Device (Biopsy)

Veran Medical Technologies (St. Louis, MO) early-stage company focused on the treatment of lung cancer using minimally invasive biopsy and ablation devices, closed a $4.8M Series A financing. Participants include Prolog Ventures and Advantage Capital Partners

Nov

2008

Arbel Medical, Ltd.: Series B $3.5M

Posted in I - Series B, Q - 2Q08, R - INTERNATIONAL, X - Device (Ablation)

Arbel Medical (Israel) commercial-stage medical device company focused on cryotherapy solutions for ablating diseased tissue, closed a $3.5M Series B financing. Participants include Giza Venture Capital, Ofer Hi-Tech and Bridge Investment Fund.

to top of page...